Terms: = Germ cell tumor AND SDHC, CYBL, 6391, ENSG00000143252, SDH3, PGL3, QPS1, CYB560 AND Diagnosis
71 results:
1. Back to Biochemistry: Evaluation for and Prognostic Significance of SDH Mutations in Paragangliomas and Pheochromocytomas.
Gupta S; Erickson LA
Surg Pathol Clin; 2023 Mar; 16(1):119-129. PubMed ID: 36739159
[TBL] [Abstract] [Full Text] [Related]
2. Kidney tumors associated with germline mutations of FH and SDHB show a CpG island methylator phenotype (CIMP).
Ricketts CJ; Killian JK; Vocke CD; Wang Y; Merino MJ; Meltzer PS; Linehan WM
PLoS One; 2022; 17(12):e0278108. PubMed ID: 36455002
[TBL] [Abstract] [Full Text] [Related]
3. Case Report: Composite pheochromocytoma with ganglioneuroma component: A report of three cases.
Araujo PB; Carvallo MS; Vidal AP; Nascimento JB; Wo JM; Naliato EO; Cunha Neto SH; Conceição FL; Fontes R; de Lima VV; Carvalho DP; Soares P; Lima J; Lourenço DM; Violante AHD
Front Endocrinol (Lausanne); 2022; 13():903085. PubMed ID: 36187102
[TBL] [Abstract] [Full Text] [Related]
4. Succinate: A Serum Biomarker of SDHB-Mutated Paragangliomas and Pheochromocytomas.
Lamy C; Tissot H; Faron M; Baudin E; Lamartina L; Pradon C; Al Ghuzlan A; Leboulleux S; Perfettini JL; Paci A; Hadoux J; Broutin S
J Clin Endocrinol Metab; 2022 Sep; 107(10):2801-2810. PubMed ID: 35948272
[TBL] [Abstract] [Full Text] [Related]
5. Succinate dehydrogenase and MYC-associated factor X mutations in pituitary neuroendocrine tumours.
Loughrey PB; Roncaroli F; Healy E; Weir P; Basetti M; Casey RT; Hunter SJ; Korbonits M
Endocr Relat Cancer; 2022 Oct; 29(10):R157-R172. PubMed ID: 35938916
[TBL] [Abstract] [Full Text] [Related]
6. sdhc phaeochromocytoma and paraganglioma: A UK-wide case series.
Williams ST; Chatzikyriakou P; Carroll PV; McGowan BM; Velusamy A; White G; Obholzer R; Akker S; Tufton N; Casey RT; Maher ER; Park SM; Porteous M; Dyer R; Tan T; Wernig F; Brady AF; Kosicka-Slawinska M; Whitelaw BC; Dorkins H; Lalloo F; Brennan P; Carlow J; Martin R; Mitchell AL; Harrison R; Hawkes L; Newell-Price J; Kelsall A; Igbokwe R; Adlard J; Schirwani S; Davidson R; Morrison PJ; Chung TT; Bowles C; Izatt L
Clin Endocrinol (Oxf); 2022 Apr; 96(4):499-512. PubMed ID: 34558728
[TBL] [Abstract] [Full Text] [Related]
7. The emerging clinical relevance of genomic profiling in neuroendocrine tumours.
Burak GI; Ozge S; Cem M; Gulgun B; Zeynep DY; Atil B
BMC Cancer; 2021 Mar; 21(1):234. PubMed ID: 33676450
[TBL] [Abstract] [Full Text] [Related]
8. Head and neck paragangliomas in Norway, importance of genetics, updated diagnostic workup and treatment.
Rana MU; Østhus AA; Heimdal K; Jebsen P; Revheim MR; Osnes TA
Acta Otolaryngol; 2021 Mar; 141(3):303-308. PubMed ID: 33320715
[TBL] [Abstract] [Full Text] [Related]
9. A Novel MAX Gene Mutation Variant in a Patient With Multiple and "Composite" Neuroendocrine-Neuroblastic tumors.
Pozza C; Sesti F; Di Dato C; Sbardella E; Pofi R; Schiavi F; Bonifacio V; Isidori AM; Faggiano A; Lenzi A; Giannetta E
Front Endocrinol (Lausanne); 2020; 11():234. PubMed ID: 32508744
[No Abstract] [Full Text] [Related]
10. Variant type is associated with disease characteristics in SDHB, sdhc and SDHD-linked phaeochromocytoma-paraganglioma.
Bayley JP; Bausch B; Rijken JA; van Hulsteijn LT; Jansen JC; Ascher D; Pires DEV; Hes FJ; Hensen EF; Corssmit EPM; Devilee P; Neumann HPH
J Med Genet; 2020 Feb; 57(2):96-103. PubMed ID: 31492822
[TBL] [Abstract] [Full Text] [Related]
11. Pheochromocytoma and paraganglioma: implications of germline mutation investigation for treatment, screening, and surveillance.
Gómez AM; Soares DC; Costa AAB; Pereira DP; Achatz MI; Formiga MN
Arch Endocrinol Metab; 2019 Jul; 63(4):369-375. PubMed ID: 31365623
[TBL] [Abstract] [Full Text] [Related]
12. Pheochromocytoma, paragangliomas, and pituitary adenoma: An unusual association in a patient with an SDHD mutation. Case report.
Lemelin A; Lapoirie M; Abeillon J; Lasolle H; Giraud S; Philouze P; Ceruse P; Raverot G; Vighetto A; Borson-Chazot F
Medicine (Baltimore); 2019 Jul; 98(30):e16594. PubMed ID: 31348302
[TBL] [Abstract] [Full Text] [Related]
13. SDHx-related pheochromocytoma/paraganglioma - genetic, clinical, and treatment outcomes in a series of 30 patients from a single center.
Donato S; Simões H; Pinto AT; M Cavaco B; Leite V
Endocrine; 2019 Aug; 65(2):408-415. PubMed ID: 31104306
[TBL] [Abstract] [Full Text] [Related]
14. Positive Impact of Genetic Test on the Management and Outcome of Patients With Paraganglioma and/or Pheochromocytoma.
Buffet A; Ben Aim L; Leboulleux S; Drui D; Vezzosi D; Libé R; Ajzenberg C; Bernardeschi D; Cariou B; Chabolle F; Chabre O; Darrouzet V; Delemer B; Desailloud R; Goichot B; Esvant A; Offredo L; Herman P; Laboureau S; Lefebvre H; Pierre P; Raingeard I; Reznik Y; Sadoul JL; Hadoux J; Tabarin A; Tauveron I; Zenaty D; Favier J; Bertherat J; Baudin E; Amar L; Gimenez-Roqueplo AP;
J Clin Endocrinol Metab; 2019 Apr; 104(4):1109-1118. PubMed ID: 30698717
[TBL] [Abstract] [Full Text] [Related]
15. The Role of Immunohistochemistry and Molecular Analysis of Succinate Dehydrogenase in the diagnosis of Endocrine and Non-Endocrine tumors and Related Syndromes.
Oudijk L; Gaal J; de Krijger RR
Endocr Pathol; 2019 Mar; 30(1):64-73. PubMed ID: 30421319
[TBL] [Abstract] [Full Text] [Related]
16. What determines mortality in malignant pheochromocytoma? - Report of a case with eighteen-year survival and review of the literature.
Andrade MO; Cunha VSD; Oliveira DC; Moraes OL; Lofrano-Porto A
Arch Endocrinol Metab; 2018; 62(2):264-269. PubMed ID: 29768630
[TBL] [Abstract] [Full Text] [Related]
17. Tracheal paraganglioma presenting as stridor in a pediatric patient, case report and literature review.
Dimachkieh AL; Dobbie A; Olson DR; Lovell MA; Prager JD
Int J Pediatr Otorhinolaryngol; 2018 Apr; 107():145-149. PubMed ID: 29501297
[TBL] [Abstract] [Full Text] [Related]
18. [Carney triad].
Fiala L; Kocáková I; Šimůnek R; Krejčí E; Babánková I; Šefr R
Rozhl Chir; 2017; 96(6):267-272. PubMed ID: 28931294
[TBL] [Abstract] [Full Text] [Related]
19. Routine genetic screening with a multi-gene panel in patients with pheochromocytomas.
Sbardella E; Cranston T; Isidori AM; Shine B; Pal A; Jafar-Mohammadi B; Sadler G; Mihai R; Grossman AB
Endocrine; 2018 Jan; 59(1):175-182. PubMed ID: 28477304
[TBL] [Abstract] [Full Text] [Related]
20. Genotype-phenotype correlation in paediatric pheochromocytoma and paraganglioma: a single centre experience from India.
Khadilkar K; Sarathi V; Kasaliwal R; Pandit R; Goroshi M; Shivane V; Lila A; Bandgar T; Shah NS
J Pediatr Endocrinol Metab; 2017 May; 30(5):575-581. PubMed ID: 28432847
[TBL] [Abstract] [Full Text] [Related]
[Next]